{"reformulated1": "What are the main challenges in maintaining product consistency and quality during large-scale recombinant monoclonal antibody manufacturing, and how do process variations impact these parameters?", "reformulated2": "How have technological innovations such as single-use bioreactors and continuous bioprocessing addressed economic and scalability challenges in the mass production of recombinant antibodies?", "reformulated3": "What strategies are employed to overcome glycosylation variability and downstream processing bottlenecks in industrial-scale recombinant antibody production?"}
